R

Repligen CorpRGEN

Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. We are 'inspiring advances in bioprocessing' for the customers we serve; primarily biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Our focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and.

US StocksBiotechnologyHealthcareMid CapGrowth Stocks

RGEN Price Trend

Repligen Corp · Full TradingView Chart

NASDAQ:RGEN

Onchain Activity